ENDOCRINE BIOMARKERS OF EARLY FETAL LOSS IN MACAQUES FOLLOWING EXPOSURE TO TCDD
接触 TCDD 后猕猴早期流产的内分泌生物标志物
基本信息
- 批准号:6116648
- 负责人:
- 金额:$ 5.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
beneath the table to the abstract. Use the Word Count cmd under
Utilites menu for counting Significance Little information is
available on embryo-maternal signaling during early pregnancy in
primates. An increased understanding of the endocrine events that
characterize this period in the nonhuman primate model will enhance
our ability to monitor spontaneous and toxicant-induced pregnancy loss
in humans. Objectives To study the endocrinology of early pregnancy
loss induced by TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) in the
cynomolgus monkey. The macaque exhibits similar endocrine and
morphological characteristics during early pregnancy as described in
humans and is sensitive to TCDD toxicity. Results Single doses of
TCDD (1, 2, and 4 mg/kg) administered during early pregnancy resulted
in fetal loss in the majority of animals (10/12). The primary
endocrine alterations associated with fetal loss were decreases in
serum estradiol and bioactive chorionic gonadotropin (CG)
concentrations. Less pronounced decreases in serum progesterone, and
relaxin were observed; there was no effect on immunoreactive CG.
These results indicate that TCDD targets specific components of the CG
synthetic machinery within the trophoblast to alter the functional
capacity of the hormone. Moreover, these endocrine alterations
occurred prior to overt signs of reproductive toxicity (i.e., early
fetal loss). The relatively long interval from TCDD exposure to fetal
loss (10-20 days) suggests that TCDD may have a direct toxic effect on
the embryo. Future Directions Use of bioactive:immunoreactive CG
ratio to monitor pregnancy outcome in human populations. KEY WORDS
abortion, pregnancy, chorionic gonadotropin, estrogen, progesterone
FUNDING NIH Grants ES06198 and RR00169
桌子下面的抽象。 使用Word Count cmd
利用菜单计算重要性信息很少
在妊娠早期,
灵长类动物 增加对内分泌事件的了解,
在非人类灵长类动物模型中描述这一时期将增强
我们监测自发性和毒物性流产的能力
在人类身上。 目的探讨早期妊娠的内分泌学
TCDD(2,3,7,8-四氯二苯并-对-二恶英)在
猕猴。 猕猴表现出类似的内分泌和
在早期妊娠期间的形态特征,如
对TCDD毒性敏感。 结果单剂量
妊娠早期给予TCDD(1、2和4 mg/kg),
在大多数动物中胎仔丢失(10/12)。 主
与胎儿丢失相关的内分泌改变减少,
血清雌二醇和生物活性绒毛膜促性腺激素
浓度的 血清孕酮下降不太明显,
松弛素的观察;免疫反应CG没有影响。
这些结果表明,TCDD的目标是CG的特定组件
滋养层内的合成机制改变功能
荷尔蒙的能力。 此外,这些内分泌变化
发生在明显的生殖毒性迹象之前(即,早期
胎儿丢失)。 TCDD暴露至胎儿的相对较长时间间隔
损失(10-20天)表明,TCDD可能对
胚胎。 生物活性物质的使用:免疫反应性CG
以监测人群中的妊娠结局。 关键词
流产,妊娠,绒毛膜促性腺激素,雌激素,孕酮
资助NIH赠款ES 06198和RR 00169
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW G HENDRICKX其他文献
ANDREW G HENDRICKX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW G HENDRICKX', 18)}}的其他基金
PATHOGENESIS OF RETINOIC ACID INDUCED EAR MALFORMATIONS IN PRIMATE MODEL
视黄酸诱发灵长类动物模型耳畸形的发病机制
- 批准号:
6116649 - 财政年份:1999
- 资助金额:
$ 5.91万 - 项目类别:
ENDOCRINE BIOMARKERS OF EARLY FETAL LOSS IN MACAQUES FOLLOWING EXPOSURE TO TCDD
接触 TCDD 后猕猴早期流产的内分泌生物标志物
- 批准号:
6277888 - 财政年份:1998
- 资助金额:
$ 5.91万 - 项目类别:
RETINOIC ACID INDUCES ABNORMAL HINDBRAIN & CRANIOFACIAL DEVELOPMENT IN MACAQUE
视黄酸导致后脑异常
- 批准号:
6277889 - 财政年份:1998
- 资助金额:
$ 5.91万 - 项目类别:
DEVELOPMENTAL TOXICITY OF EXCESSIVE VITAMIN INTAKE IN MACAQUE
猕猴摄入过多维生素的发育毒性
- 批准号:
6277887 - 财政年份:1998
- 资助金额:
$ 5.91万 - 项目类别:
IN VIVO BIOMARKERS FOR REPRODUCTIVE TOXICITY IN NON-HUMAN PRIMATES
非人类灵长类动物生殖毒性的体内生物标志物
- 批准号:
6106367 - 财政年份:1997
- 资助金额:
$ 5.91万 - 项目类别:
DEVELOPMENTAL TOXICITY ASSESSMENT OF VITAMIN IN CYNOMOLGUS MONKEY
食蟹猴维生素的发育毒性评估
- 批准号:
6247758 - 财政年份:1997
- 资助金额:
$ 5.91万 - 项目类别:
BIOMARKERS OF EARLY FETAL LOSS IN MACAQUES TCDD: ENVIRONMENTAL TOXICITY MODEL
猕猴早期流产的生物标志物 TCDD:环境毒性模型
- 批准号:
6247757 - 财政年份:1997
- 资助金额:
$ 5.91万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 5.91万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 5.91万 - 项目类别: